GlobeNewswire·2026-11-17

Integer Completes Acquisition by KKR in $5.7 Billion Transaction

KKR has completed its acquisition of medical device CDMO Integer Holdings Corporation in a transaction valued at an enterprise value of approximately $5.7 billion.

Global investment firm KKR has finalized its acquisition of Integer Holdings Corporation in a transaction valued at an enterprise value of approximately $5.7 billion. The completion of the deal follows an initial agreement announced on August 3, 2026, and formal approval by Integer's stockholders on October 21, 2026.

Under the terms of the transaction, Integer stockholders receive $127 per share in cash. With the closing of the deal, the company's common stock has ceased trading and will no longer be listed on the New York Stock Exchange. The transaction transfers ownership of the medical device contract development and manufacturing organization (CDMO) to an affiliate of investment funds managed by KKR.

Headquartered in Plano, Texas, Integer operates as one of the largest medical device CDMOs globally, serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. Its brand portfolio includes Greatbatch Medical and Lake Region Medical. Alongside KKR, the company plans to accelerate its growth strategy and further invest in its people, capabilities, and technologies.

Company leadership will remain in place, with President and CEO Payman Khales continuing to lead alongside the management team. KKR partner Max Lin stated that the firm sees significant opportunities to leverage its resources and expertise to support Integer's next phase of growth, expand its capabilities, and strengthen its position as a trusted partner to the global medical device industry.